Bank of New York Mellon’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21.4M | Buy |
388,082
+11,219
| +3% | +$620K | ﹤0.01% | 1473 |
|
2025
Q1 | $18.2M | Sell |
376,863
-13,925
| -4% | -$673K | ﹤0.01% | 1548 |
|
2024
Q4 | $15.1M | Buy |
390,788
+34,455
| +10% | +$1.33M | ﹤0.01% | 1717 |
|
2024
Q3 | $16M | Buy |
356,333
+152,034
| +74% | +$6.84M | ﹤0.01% | 1698 |
|
2024
Q2 | $7.08M | Buy |
204,299
+17,065
| +9% | +$591K | ﹤0.01% | 2148 |
|
2024
Q1 | $5.42M | Sell |
187,234
-15,943
| -8% | -$461K | ﹤0.01% | 2283 |
|
2023
Q4 | $4.66M | Buy |
203,177
+1,733
| +0.9% | +$39.7K | ﹤0.01% | 2399 |
|
2023
Q3 | $3.36M | Buy |
201,444
+1,869
| +0.9% | +$31.2K | ﹤0.01% | 2532 |
|
2023
Q2 | $5.51M | Buy |
199,575
+31,042
| +18% | +$857K | ﹤0.01% | 2268 |
|
2023
Q1 | $3.88M | Buy |
168,533
+4,208
| +3% | +$96.8K | ﹤0.01% | 2440 |
|
2022
Q4 | $1.79M | Buy |
164,325
+6,266
| +4% | +$68.4K | ﹤0.01% | 2910 |
|
2022
Q3 | $1.33M | Buy |
158,059
+15,988
| +11% | +$135K | ﹤0.01% | 3066 |
|
2022
Q2 | $1.12M | Buy |
142,071
+2,302
| +2% | +$18.2K | ﹤0.01% | 3158 |
|
2022
Q1 | $3.31M | Buy |
139,769
+1,275
| +0.9% | +$30.2K | ﹤0.01% | 2650 |
|
2021
Q4 | $4.74M | Buy |
138,494
+7,361
| +6% | +$252K | ﹤0.01% | 2491 |
|
2021
Q3 | $2.32M | Sell |
131,133
-15,197
| -10% | -$269K | ﹤0.01% | 2894 |
|
2021
Q2 | $6.57M | Buy |
146,330
+12,735
| +10% | +$572K | ﹤0.01% | 2366 |
|
2021
Q1 | $3.46M | Buy |
133,595
+4,291
| +3% | +$111K | ﹤0.01% | 2627 |
|
2020
Q4 | $2.61M | Buy |
129,304
+34,850
| +37% | +$703K | ﹤0.01% | 2684 |
|
2020
Q3 | $1.85M | Sell |
94,454
-6,898
| -7% | -$135K | ﹤0.01% | 2713 |
|
2020
Q2 | $1.79M | Buy |
101,352
+17,769
| +21% | +$314K | ﹤0.01% | 2746 |
|
2020
Q1 | $590K | Buy |
83,583
+1
| +0% | +$7 | ﹤0.01% | 3269 |
|
2019
Q4 | $589K | Buy |
83,582
+6,180
| +8% | +$43.6K | ﹤0.01% | 3507 |
|
2019
Q3 | $930K | Sell |
77,402
-26,686
| -26% | -$321K | ﹤0.01% | 3213 |
|
2019
Q2 | $1.26M | Buy |
104,088
+41,052
| +65% | +$497K | ﹤0.01% | 3068 |
|
2019
Q1 | $792K | Sell |
63,036
-233
| -0.4% | -$2.93K | ﹤0.01% | 3314 |
|
2018
Q4 | $426K | Hold |
63,269
| – | – | ﹤0.01% | 3566 |
|
2018
Q3 | $651K | Hold |
63,269
| – | – | ﹤0.01% | 3503 |
|
2018
Q2 | $426K | Buy |
63,269
+13,303
| +27% | +$89.6K | ﹤0.01% | 3693 |
|
2018
Q1 | $430K | Buy |
49,966
+5,493
| +12% | +$47.3K | ﹤0.01% | 3638 |
|
2017
Q4 | $925K | Buy |
44,473
+15,412
| +53% | +$321K | ﹤0.01% | 3288 |
|
2017
Q3 | $513K | Buy |
29,061
+1,435
| +5% | +$25.3K | ﹤0.01% | 3577 |
|
2017
Q2 | $313K | Buy |
27,626
+1,478
| +6% | +$16.7K | ﹤0.01% | 3801 |
|
2017
Q1 | $335K | Buy |
26,148
+3,433
| +15% | +$44K | ﹤0.01% | 3710 |
|
2016
Q4 | $500K | Buy |
22,715
+8,513
| +60% | +$187K | ﹤0.01% | 3593 |
|
2016
Q3 | $301K | Buy |
+14,202
| New | +$301K | ﹤0.01% | 3758 |
|